Evusheld is approved in UK for prophylaxis in immunocompromised people9 Aug. 2022
The drug Evusheld has been approved by the MHRA (Medicines and Healthcare products Regulatory Agency), but the government has not yet made a decision whether to make it available to patients.
We are continuing to monitor the access issues and joining the request of all blood cancer charities to make this drug available to immunocompromised patients, in particular blood cancer patients who have not responded sufficiently to the Covid-19 vaccines to date.
You can help by writing to your MP, asking them to add pressure to the government, to make the drug accessible.
For tips on writing to your MP, and how to find their contact details see the
The Results website
Click this link to visit the Results website https://www.results.org.uk/guides/how-write-your-mp
Do quote both Evusheld articles below and explain that MDS patients need this additional treatment option, to have a semblance of normal life.
'Evusheld is Approved in UK' by Jacqui Wise - Click this link to read the BMJ (British Medical Journal) article on Evusheld https://www.bmj.com/content/376/bmj.o722
'Clinicians call for Anti-Covid Treatment to be Available in the UK' - Click this link to read the Medscape UK article by Siobhan Harris. https://www.medscape.co.uk/viewarticle/
The APPGs (All-Party Parliamentary Groups) on Blood Cancer and Henry Smith MP, are also seeking answers on behalf of all blood cancer patients.
Click the link below to read about Henry Smith's role as the chair of the All-Party Parliamentary Group on Blood Cancer https://www.henrysmith.info/bloodcancer